Calpains as potential anti-cancer targets

Bibliography

• Goll DE, Thompson VF, Li H, The calpain system. Physiol Rev 2003;83:731-801
   PubMed Web of Science ®Google Scholar
• Schad E, Farkas A, Jekely G, A novel human small subunit of calpains. Biochem J 2002;362:383-8
   PubMedGoogle Scholar
• Kulkarni S, Goll DE, Fox JEB. Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J Biol Chem 2002;277:24435-41
   PubMed Web of Science ®Google Scholar
• Huang C, Rajfur Z, Yousefi N, Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol 2009;11:624-30
   PubMed Web of Science ®Google Scholar
• Gregoriou M, Willis AC, Pearson MA, The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Eur J Biochem 1994;223:455-64
   PubMedGoogle Scholar
• Franco SJ, Rodgers MA, Perrin BJ, Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 2004;6:977-83
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Oda N, Cox NJ, Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-75
   PubMed Web of Science ®Google Scholar
• Saito K, Elce JS, Hamos JE, Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993;90:2628-32
   PubMed Web of Science ®Google Scholar
• Mellgren RL. Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase. Biochem Biophys Res Commun 1997;236:555-8
   PubMed Web of Science ®Google Scholar
• Janossy J, Ubezio P, Apati A, Calpain as a multi-site regulator of cell cycle. Biochem Pharmacol 2004;67:1513-21
   PubMedGoogle Scholar
• Joy J, Nalabothula N, Ghosh M, Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d). Biol Chem 2006;387:329-35
   PubMed Web of Science ®Google Scholar
• Choi YH, Lee SJ, Nguyen P, Regulation of cyclin D1 by calpain protease. J Biol Chem 1997;272:28479-84
   PubMed Web of Science ®Google Scholar
• Wang XD, Rosales JL, Magliocco A, Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 2003;22:769-74
   PubMed Web of Science ®Google Scholar
• Chen Z, Knutson E, Kurosky A, Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol 2001;75:3613-25
   PubMed Web of Science ®Google Scholar
• Delmas C, Aragou N, Poussard S, MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J Biol Chem 2003;278:12443-51
   PubMed Web of Science ®Google Scholar
• Smith PD, Mount MP, Shree R, Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 2006;26:440-7
   PubMed Web of Science ®Google Scholar
• Squier MK, Miller AC, Malkinson AM, Calpain activation in apoptosis. J Cell Physiol 1994;159:229-37
   PubMed Web of Science ®Google Scholar
• Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 2000;275:5131-5
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000;150:887-94
   PubMed Web of Science ®Google Scholar
• Wang KK. Calpain and caspase: can you tell the difference? Trends Neurosci 2000;23:20-6
   PubMed Web of Science ®Google Scholar
• Kubbutat MH, Vousden KH. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 1997;17:460-8
   PubMed Web of Science ®Google Scholar
• Glading A, Lauffenburger DA, Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002;12:46-54
   PubMed Web of Science ®Google Scholar
• Bhatt A, Kaverina I, Otey C, Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J Cell Sci 2002;115:3415-25
   PubMed Web of Science ®Google Scholar
• Sheetz MP, Felsenfeld D, Galbraith CG, Cell migration as a five-step cycle. Biochem Soc Symp 1999;65:233-43
   PubMed Web of Science ®Google Scholar
• Shao H, Chou J, Baty CJ, Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol 2006;26:5481-96
   PubMed Web of Science ®Google Scholar
• Leloup L, Shao H, Bae YH, m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2010;285:33549-66
   PubMed Web of Science ®Google Scholar
• Franco S, Perrin B, Huttenlocher A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp Cell Res 2004;299:179-87
   PubMed Web of Science ®Google Scholar
• Mamoune A, Luo J, Lauffenburger DA, Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res 2003;63:4632-40
   PubMed Web of Science ®Google Scholar
• Cortesio CL, Chan KT, Perrin BJ, Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol 2008;180:957-71
   PubMedGoogle Scholar
• Popp O, Heidinger M, Ruiz-Heinrich L, The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells. Biol Chem 2003;384:951-8
   PubMed Web of Science ®Google Scholar
• Carragher NO, Frame MC. Calpain: a role in cell transformation and migration. Int J Biochem Cell Biol 2002;34:1539-43
   PubMed Web of Science ®Google Scholar
• Carragher NO, Westhoff MA, Riley D, v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation. Mol Cell Biol 2002;22:257-69
   PubMed Web of Science ®Google Scholar
• Carragher NO, Fonseca BD, Frame MC. Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 2004;6:53-73
   PubMed Web of Science ®Google Scholar
• Niapour M, Yu Y, Berger SA. Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression. J Biol Chem 2008;283:21371-81
   PubMedGoogle Scholar
• Ciuffini L, Castellani L, Salvati E, Delineating v-Src downstream effector pathways in transformed myoblasts. Oncogene 2008;27:528-39
   PubMed Web of Science ®Google Scholar
• Small GW, Chou T, Dang CV, Evidence for involvement of calpain in c-Myc proteolysis in vivo. Arch Biochem Biophys 2002;400:151-61
   PubMed Web of Science ®Google Scholar
• Sergeev IN. Genistein induces Ca2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Biophys Res Commun 2004;321:462-7
   PubMedGoogle Scholar
• Martinez JA, Zhang Z, Svetlov SI, Calpain and caspase processing of caspase-12 contribute to the ER stress-induced cell death pathway in differentiated PC12 cells. Apoptosis 2010;15:1480-93
   PubMed Web of Science ®Google Scholar
• Tan Y, Dourdin N, Wu C, Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 2006;281:16016-24
   PubMed Web of Science ®Google Scholar
• Shim H, Park J, Paik H, Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Anticancer Drugs 2007;18:649-57
   PubMed Web of Science ®Google Scholar
• Yeh T, Chiang P, Li T, Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol 2007;73:782-92
   PubMed Web of Science ®Google Scholar
• Das A, Banik NL, Ray SK. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer 2010;116:164-76
   PubMed Web of Science ®Google Scholar
• Sareen D, Darjatmoko SR, Albert DM, Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 2007;72:1466-75
   PubMed Web of Science ®Google Scholar
• Xie S, Zhang Z, Hu G, HL-37, a novel anthracene derivative, induces Ca2+-mediated apoptosis in human breast cancer cells. Toxicology 2008;254:68-74
   PubMed Web of Science ®Google Scholar
• Liu L, Xing D, Chen WR, Calpain-mediated pathway dominates cisplatin-induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis. Int J Cancer 2008;122:2210-22
   PubMedGoogle Scholar
• Liu L, Xing D, Chen WR. Micro-calpain regulates caspase-dependent and apoptosis inducing factor-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis. Int J Cancer 2009;125:2757-66
   PubMed Web of Science ®Google Scholar
• Anguissola S, Kohler B, O'Byrne R, Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cells. Mol Pharmacol 2009;76:998-1010
   PubMedGoogle Scholar
• Wu Z, Chao CC. Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: implications to overcome chemoresistance. Biochem Pharmacol 2010;80:827-37
   PubMedGoogle Scholar
• Lee SK, Park MS, Nam MJ. Aspirin has antitumor effects via expression of calpain gene in cervical cancer cells. J Oncol 2008;2008:285374
   PubMedGoogle Scholar
• Karmakar S, Banik NL, Patel SJ, Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci Lett 2006;407:53-8
   PubMed Web of Science ®Google Scholar
• Karmakar S, Banik NL, Ray SK. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res 2007;32:2103-13
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Reddy KB, Esteva FJ, Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer. Oncogene 2010;29:1339-50
   PubMed Web of Science ®Google Scholar
• Li C, Chen S, Yue P, Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaBalpha degradation. J Biol Chem 2010;285:16096-104
   PubMed Web of Science ®Google Scholar
• Wells A, Kassis J, Solava J, Growth factor-induced cell motility in tumor invasion. Acta Oncol 2002;41:124-30
   PubMed Web of Science ®Google Scholar
• Kassis J, Radinsky R, Wells A. Motility is rate-limiting for invasion of bladder carcinoma cell lines. Int J Biochem Cell Biol 2002;34:762-75
   PubMedGoogle Scholar
• Huttenlocher A, Ginsberg MH, Horwitz AF. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 1996;134:1551-62
   PubMed Web of Science ®Google Scholar
• Dourdin N, Bhatt AK, Dutt P, Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 2001;276:48382-8
   PubMed Web of Science ®Google Scholar
• Bodnar RJ, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 2006;98:617-25
   PubMed Web of Science ®Google Scholar
• Su Y, Cui Z, Li Z, Calpain-2 regulation of VEGF-mediated angiogenesis. FASEB J 2006;20:1443-51
   PubMed Web of Science ®Google Scholar
• Satish L, Blair HC, Glading A, Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol Cell Biol 2005;25:1922-41
   PubMedGoogle Scholar
• Dedieu S, Poussard S, Mazeres G, Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp Cell Res 2004;292:187-200
   PubMed Web of Science ®Google Scholar
• Leloup L, Mazeres G, Daury L, Involvement of calpains in growth factor-mediated migration. Int J Biochem Cell Biol 2006;38:2049-63
   PubMed Web of Science ®Google Scholar
• Glading A, Chang P, Lauffenburger DA, Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 2000;275:2390-8
   PubMed Web of Science ®Google Scholar
• Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001;37(Suppl 4):S9-15
   PubMed Web of Science ®Google Scholar
• Xu L, Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of μ- and m-calpain in association with increased secretion, cell migration, and invasion. J Biol Chem 2004;279:53683-90
   PubMed Web of Science ®Google Scholar
• Xu L, Deng X. Protein kinase Cι promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of mu- and m-calpains. J Biol Chem 2006;281:4457-66
   PubMedGoogle Scholar
• Meng XN, Jin Y, Yu Y, Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 2009;101:327-34
   PubMed Web of Science ®Google Scholar
• Roumes H, Leloup L, Dargelos E, Calpains: markers of tumor aggressiveness? Exp Cell Res 2010;316:1587-99
   PubMedGoogle Scholar
• Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907:191-217
   PubMed Web of Science ®Google Scholar
• Fan D, Dai J, Tang J, Silencing of calpain expression reduces the metastatic potential of human osteosarcoma cells. Cell Biol Int 2009;33:1263-7
   PubMedGoogle Scholar
• Brustis JJ, Elamrani N, Balcerzak D, Rat myoblast fusion requires exteriorized m-calpain activity. Eur J Cell Biol 1994;64:320-7
   PubMed Web of Science ®Google Scholar
• Xu L, Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J Biol Chem 2006;281:35567-75
   PubMed Web of Science ®Google Scholar
• Carragher NO, Walker SM, Scott Carragher LA, Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene 2006;25:5726-40
   PubMed Web of Science ®Google Scholar
• Martiny-Baron G, Marme D. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr Opin Biotechnol 1995;6:675-80
   PubMed Web of Science ®Google Scholar
• Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997;1333:F179-99
   PubMed Web of Science ®Google Scholar
• Allegra CJ, Yothers G, O'Connell MJ, Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 2011;29:11-16
   PubMed Web of Science ®Google Scholar
• Bodnar RJ, Yates CC, Rodgers ME, IP-10 induces dissociation of newly formed blood vessels. J Cell Sci 2009;122:2064-77
   PubMed Web of Science ®Google Scholar
• Shiraha H, Glading A, Chou J, Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol 2002;22:2716-27
   PubMed Web of Science ®Google Scholar
• Lasagni L, Francalanci M, Annunziato F, An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 2003;197:1537-49
   PubMed Web of Science ®Google Scholar
• Ono Y, Shimada H, Sorimachi H, Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 1998;273:17073-8
   PubMed Web of Science ®Google Scholar
• Moretti D, Del Bello B, Cosci E, Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis 2009;30:960-7
   PubMedGoogle Scholar
• Roperto S, De Tullio R, Raso C, Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle. PLoS ONE 2010;5:e10299
   Google Scholar
• Lee S, Kim B, Choi Y, Increased expression of calpain 6 during the progression of uterine cervical neoplasia: immunohistochemical analysis. Oncol Rep 2008;19:859-63
   PubMedGoogle Scholar
• Rho SB, Byun H, Park S, Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis. Cancer Lett 2008;271:306-13
   PubMedGoogle Scholar
• Yoshikawa Y, Mukai H, Hino F, Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 2000;91:459-63
   PubMedGoogle Scholar
• Liu K, Li L, Cohen SN. Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumorigenesis. J Biol Chem 2000;275:31093-8
   PubMedGoogle Scholar
• Shiba E, Kambayashi JI, Sakon M, Ca2+-dependent neutral protease (calpain) activity in breast cancer tissue and estrogen receptor status. Breast Cancer 1996;3:13-17
   PubMedGoogle Scholar
• Lakshmikuttyamma A, Selvakumar P, Kanthan R, Overexpression of m-calpain in human colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev 2004;13:1604-9
   PubMed Web of Science ®Google Scholar
• Das A, Banik NL, Patel SJ, Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 2004;3:36
   PubMed Web of Science ®Google Scholar
• Rios-Doria J, Day KC, Kuefer R, The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 2003;278:1372-9
   PubMed Web of Science ®Google Scholar
• Reichrath J, Welter C, Mitschele T, Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. J Pathol 2003;199:509-16
   PubMedGoogle Scholar
• Braun C, Engel M, Seifert M, Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int J Cancer 1999;84:6-9
   PubMed Web of Science ®Google Scholar
• Daniel KG, Anderson JS, Zhong Q, Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis. Int J Mol Med 2003;12:247-52
   PubMedGoogle Scholar
• Bai D, Dai Z, Zhou J, Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology 2009;49:460-70
   PubMed Web of Science ®Google Scholar
• Kothapalli R, Bailey RD, Kusmartseva I, Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 2003;22:33-9
   PubMed Web of Science ®Google Scholar
• Salehin D, Fromberg I, Haugk C, Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer. Anticancer Res 2010;30:2837-43
   PubMed Web of Science ®Google Scholar
• Esteban F, Royo JL, Gonzalez-Moles MA, CAPN10 alleles modify laryngeal cancer risk in the Spanish population. Eur J Surg Oncol 2008;34:94-9
   PubMedGoogle Scholar
• Akashiba H, Matsuki N, Nishiyama N. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons. J Neurochem 2006;99:733-44
   PubMedGoogle Scholar
• Kaneko T, Yamashima T, Tohma Y, Calpain-dependent proteolysis of merlin occurs by oxidative stress in meningiomas: a novel hypothesis of tumorigenesis. Cancer 2001;92:2662-72
   PubMedGoogle Scholar
• Averna M, Stifanese R, De Tullio R, Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells. J Neurochem 2009;110:412-21
   PubMedGoogle Scholar
• Chen C, Nguyen T, Shively JE. Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells. Exp Cell Res 2010;316:638-48
   PubMedGoogle Scholar